Andes Biotechnologies
Provider of nucleic acid-based drugs for the treatment of solid tumor cancers. It offers a proprietary antisense oligonucleotide that targets a novel non-coding mitochondrial RNA (ncmtRNA) and has demonstrated antineoplastic activity in preclinical studies. The Company currently has multiple investigational drug candidates in its pipeline targeting various solid tumor cancer indications. Founded in 2008,…
Funding snapshot
About
Provider of nucleic acid-based drugs for the treatment of solid tumor cancers. It offers a proprietary antisense oligonucleotide that targets a novel non-coding mitochondrial RNA (ncmtRNA) and has demonstrated antineoplastic activity in preclinical studies. The Company currently has multiple investigational drug candidates in its pipeline targeting various solid tumor cancer indications. Founded in 2008, headquartered in Santiago, Chile. The company has raised $16. The company operates in Life Sciences > Genomics, Life Sciences > Gene Therapy, High Tech > Nanotechnology, Life Sciences > Oncology. Its business models include Nanotechnology > Nanotools > Genomics > RNA Sequencing, Oncology > Drugs > Diversified, Genomics > Enabling Technologies > Technology Platforms > RNA interference. Founded in 2008. Headquartered in Chile, Santiago. The company has raised funding at the Series B stage. Backed by investors including Aurus, Austral Capital, Prisma Group.
Business model
Nanotechnology > Nanotools > Genomics > RNA Sequencing,
Oncology > Drugs > Diversified,
Genomics > Enabling Technologies > Technology Platforms > RNA interference
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Andes Biotechnologies?
Analyze your pitch deck before your next raise.
Analyze My Deck →